Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-27T08:43:55.967Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of two sperm antigens, rSMP-B and YWK-II, as targets for immunocontraception

Published online by Cambridge University Press:  14 May 2001

Masaya Takikawa ,
Masaharu Kamada ,
Masahiko Maegawa ,
Shuji Yamano ,
Minoru Irahara ,
Toshihiro Aono ,
Siroh Futaki ,
Yasukazu Ohmoto  and
Samuel S. Koide
Masaya Takikawa
Affiliation:
Department of Obstetrics and Gynecology, School of Medicine, The University of Tokushima, Tokushima, Japan.
Masaharu Kamada
Affiliation:
Department of Obstetrics and Gynecology, School of Medicine, The University of Tokushima, Tokushima, Japan.
Masahiko Maegawa
Affiliation:
Department of Obstetrics and Gynecology, School of Medicine, The University of Tokushima, Tokushima, Japan.
Shuji Yamano
Affiliation:
Department of Obstetrics and Gynecology, School of Medicine, The University of Tokushima, Tokushima, Japan.
Minoru Irahara
Affiliation:
Department of Obstetrics and Gynecology, School of Medicine, The University of Tokushima, Tokushima, Japan.
Toshihiro Aono
Affiliation:
Department of Obstetrics and Gynecology, School of Medicine, The University of Tokushima, Tokushima, Japan.
Siroh Futaki
Affiliation:
Pharmaceutical Science, The University of Tokushima, Tokushima, Japan.
Yasukazu Ohmoto
Affiliation:
Cellular Technology Institute, Otsuka Pharmaceutical Co., Ltd, Tokushima, Japan.
Samuel S. Koide
Affiliation:
Center for Biomedical Research, The Population Council, New York, USA.
Get access Rights & Permissions [Opens in a new window]

Abstract

To determine whether sperm membrane components, rSMP-B and YWK-II, are suitable candidates as immunocontraceptives in humans, antifertility activities of the antibodies to the peptide fragments, rSMP-229 and rSMP-230 of rSMP-B and YAL-198 of YWK-II, were examined. In a previous report, anti-rSMP-230 antibody was shown to immobilise human sperm and to block human fertilisation, and the antigen (rSMP-230) to interact with antisperm antibodies found in sera of infertile women. Antibody to the second synthetic peptide, rSMP-229, corresponding to a different segment of rSMP-B, mimicked the biological activities of the anti-rSMP-230 antibody. Anti-YAL-198 antibody significantly, although weakly, inhibited human fertilisation. In the murine model, the anti-rSMP-B antibodies blocked in vitro fertilisation of mouse eggs but had no influence on embryo growth. Anti-YAL-198 antibody, however, arrested the growth of zygotes. In conclusion, rSMP-B, a human sperm protein, is a promising candidate in the development of an immunocontraceptive for human application. A second sperm protein, YWK-II, is effective as an antifertility immunogen in experimental animals.

Keywords

Antisperm antibodyContraceptionEmbryo growthFertilisationHuman sperm protein
Type
Research Article
Information
Zygote , Volume 9 , Issue 2 , May 2001 , pp. 145 - 151
Copyright
2001 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)